YU42484B - Process for obtaining new n-heterocyclyl-4-piperidine amines - Google Patents

Process for obtaining new n-heterocyclyl-4-piperidine amines

Info

Publication number
YU42484B
YU42484B YU784/79A YU78479A YU42484B YU 42484 B YU42484 B YU 42484B YU 784/79 A YU784/79 A YU 784/79A YU 78479 A YU78479 A YU 78479A YU 42484 B YU42484 B YU 42484B
Authority
YU
Yugoslavia
Prior art keywords
heterocyclyl
obtaining new
piperidine amines
piperidine
amines
Prior art date
Application number
YU784/79A
Other languages
English (en)
Other versions
YU78479A (en
Inventor
F Janssens
R Stokbroekx
J Torremans
M Luyckx
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26670178&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU42484(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/002,276 external-priority patent/US4219559A/en
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of YU78479A publication Critical patent/YU78479A/xx
Publication of YU42484B publication Critical patent/YU42484B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
YU784/79A 1978-04-03 1979-04-03 Process for obtaining new n-heterocyclyl-4-piperidine amines YU42484B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89253478A 1978-04-03 1978-04-03
US06/002,276 US4219559A (en) 1979-01-10 1979-01-10 N-Heterocyclyl-4-piperidinamines

Publications (2)

Publication Number Publication Date
YU78479A YU78479A (en) 1983-10-31
YU42484B true YU42484B (en) 1988-10-31

Family

ID=26670178

Family Applications (2)

Application Number Title Priority Date Filing Date
YU784/79A YU42484B (en) 1978-04-03 1979-04-03 Process for obtaining new n-heterocyclyl-4-piperidine amines
YU502/83A YU43158B (en) 1978-04-03 1983-03-02 Process for obtaining new substituted 4-piperidine amines

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU502/83A YU43158B (en) 1978-04-03 1983-03-02 Process for obtaining new substituted 4-piperidine amines

Country Status (29)

Country Link
EP (1) EP0005318B1 (ja)
JP (2) JPS54151982A (ja)
AT (1) AT373887B (ja)
AU (1) AU523352B2 (ja)
BG (1) BG38164A3 (ja)
CA (1) CA1140119A (ja)
CS (1) CS256358B2 (ja)
CY (1) CY1250A (ja)
DE (1) DE2961740D1 (ja)
DK (1) DK169325B1 (ja)
EG (1) EG13913A (ja)
ES (1) ES479206A1 (ja)
FI (1) FI64801C (ja)
GR (1) GR64907B (ja)
HK (1) HK3184A (ja)
HU (1) HU182965B (ja)
IE (1) IE47818B1 (ja)
IL (1) IL56992A (ja)
MY (1) MY8500046A (ja)
NO (2) NO154058C (ja)
NZ (1) NZ189978A (ja)
PH (1) PH15877A (ja)
PL (1) PL123380B1 (ja)
PT (1) PT69429A (ja)
RO (1) RO79320A (ja)
SG (1) SG29883G (ja)
SU (1) SU1056902A3 (ja)
YU (2) YU42484B (ja)
ZA (1) ZA791557B (ja)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA19091A1 (fr) * 1980-03-10 1981-10-01 Janssen Pharmaceutica Nv Nouveaux derives de i-(4-aryl-cyclohexyl)piperidine .
US4556660A (en) * 1982-07-12 1985-12-03 Janssen Pharmaceutica N.V. N-(Bicyclic heterocyclyl)-4-piperidinamines
IN156065B (ja) * 1982-07-12 1985-05-04 Janssen Pharmaceutica Nv
US4634704A (en) * 1983-10-06 1987-01-06 Janssen Pharmaceutica, N.V. Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines
EP0144101B1 (en) * 1983-11-30 1991-02-06 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing n-(bicyclic heterocyclyl)-4-piperidinamines
PL144514B1 (en) * 1984-01-09 1988-06-30 Janssen Pharmaceutica Nv Method of obtaining novel derivatives of n-/4-piperidinolo/-2-imidazoloamine
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
GB8515934D0 (en) * 1985-06-24 1985-07-24 Janssen Pharmaceutica Nv (4-piperidinomethyl and-hetero)purines
CA1327579C (en) * 1986-02-03 1994-03-08 Frans Eduard Janssens Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines
NZ223654A (en) * 1987-03-09 1990-03-27 Janssen Pharmaceutica Nv 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions
FR2618435B1 (fr) * 1987-07-23 1989-10-27 Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
US5210091A (en) * 1991-06-24 1993-05-11 Neurosearch A/S Imidazole compounds and their use
EP0699668A4 (en) * 1993-05-20 1996-09-18 Kissei Pharmaceutical DERIVATIVE 1- (2-BENZIMIDAZOLYL) -1,5-DIAZACYCLOOCTANE
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
PL343435A1 (en) * 1998-03-06 2001-08-13 Janssen Pharmaceutica Nv Glycine transport inhibitors
EP1196410B1 (en) 1999-06-28 2004-02-18 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors
OA11978A (en) 1999-06-28 2006-04-18 Janssen Pharmaceutica Nv Respiratory syncytial virus replication inhibitors.
PT1196409E (pt) 1999-06-28 2004-06-30 Janssen Pharmaceutica Nv Inibidores da replicacao do virus sincicial respiratorio
KR20080059687A (ko) 2000-03-06 2008-06-30 아카디아 파마슈티칼스 인코포레이티드 세로토닌 관련 질병의 치료에 사용되는 아자시클릭 화합물
WO2002062786A1 (en) 2001-02-02 2002-08-15 Teva Pharmaceutical Industries Ltd. Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1h-benzimidazoles
CN101050215A (zh) 2001-12-28 2007-10-10 阿卡蒂亚药品公司 作为单胺受体调节剂的螺氮杂环化合物
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
RU2320646C2 (ru) 2002-06-24 2008-03-27 Акадиа Фармасьютикалз Инк. N-замещенные производные пиперидина в качестве агентов серотонинового рецептора
US7538222B2 (en) 2002-06-24 2009-05-26 Acadia Pharmaceuticals, Inc. N-substituted piperidine derivatives as serotonin receptor agents
US7253186B2 (en) 2002-06-24 2007-08-07 Carl-Magnus Andersson N-substituted piperidine derivatives as serotonin receptor agents
US7601740B2 (en) 2003-01-16 2009-10-13 Acadia Pharmaceuticals, Inc. Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
US7355051B2 (en) * 2003-12-18 2008-04-08 Tibotec Pharmaceuticals Piperdine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
EP1697343B1 (en) 2003-12-18 2009-07-01 Tibotec Pharmaceuticals Ltd. Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication
WO2005058874A1 (en) 2003-12-18 2005-06-30 Tibotec Pharmaceuticals Ltd. 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
US7820695B2 (en) 2004-05-21 2010-10-26 Acadia Pharmaceuticals, Inc. Selective serotonin receptor inverse agonists as therapeutics for disease
US20050261278A1 (en) 2004-05-21 2005-11-24 Weiner David M Selective serotonin receptor inverse agonists as therapeutics for disease
US7790899B2 (en) 2004-09-27 2010-09-07 Acadia Pharmaceuticals, Inc. Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
ES2530258T3 (es) 2004-09-27 2015-02-27 Acadia Pharmaceuticals Inc. Síntesis de una forma cristalina de sal tartrato de N-(4-fluorobencil)-N-(1-metilpiperidin-4-il)-N'-(4-(2-metilpropiloxi)fenilmetil)carbamida
PL2134330T3 (pl) 2007-03-19 2013-10-31 Acadia Pharm Inc Kombinacje odwrotnych agonistów i antagonistów 5-HT2A z antypsychotykami
EP3325444B1 (en) 2015-07-20 2021-07-07 Acadia Pharmaceuticals Inc. Methods for preparing n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form c
US10953000B2 (en) 2016-03-25 2021-03-23 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome P450 modulators
WO2017165635A1 (en) 2016-03-25 2017-09-28 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome p450 modulators
WO2018118626A1 (en) 2016-12-20 2018-06-28 Acadia Pharmaceuticals Inc. Pimavanserin alone or in combination for use in the treatment of alzheimer's disease psychosis
US11135211B2 (en) 2017-04-28 2021-10-05 Acadia Pharmaceuticals Inc. Pimavanserin for treating impulse control disorder
US20210077479A1 (en) 2017-08-30 2021-03-18 Acadia Pharmaceuticals Inc. Formulations of pimavanserin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2857391A (en) * 1955-04-15 1958-10-21 Merck & Co Inc Aminomethylbenzimidazoles
US2971005A (en) * 1958-10-17 1961-02-07 Merck & Co Inc Nu-substituted derivatives of 2-benzylaminobenzimidazoles
BE788065A (fr) * 1971-08-26 1973-02-26 Degussa Nouvelles aza-benzimidazoles et procede pour leur preparation

Also Published As

Publication number Publication date
GR64907B (en) 1980-06-07
NO154058C (no) 1986-07-09
ZA791557B (en) 1980-11-26
ES479206A1 (es) 1979-12-16
JPH0240666B2 (ja) 1990-09-12
DK129879A (da) 1979-10-04
ATA242579A (de) 1983-07-15
NZ189978A (en) 1984-05-31
AT373887B (de) 1984-02-27
CS222779A2 (en) 1987-03-12
BG38164A3 (en) 1985-10-15
JPH01117880A (ja) 1989-05-10
AU523352B2 (en) 1982-07-22
HK3184A (en) 1984-01-20
FI791084A (fi) 1979-10-04
IL56992A0 (en) 1979-07-25
NO154090C (no) 1986-07-16
YU78479A (en) 1983-10-31
NO791097L (no) 1979-10-04
NO154058B (no) 1986-04-01
SG29883G (en) 1984-04-19
EG13913A (en) 1982-09-30
CS256358B2 (en) 1988-04-15
YU43158B (en) 1989-04-30
PT69429A (pt) 1979-05-01
PL123380B1 (en) 1982-10-30
NO842563L (no) 1979-10-04
CY1250A (en) 1984-08-31
SU1056902A3 (ru) 1983-11-23
DK169325B1 (da) 1994-10-10
IE47818B1 (en) 1984-06-27
IE790676L (en) 1979-10-03
CA1140119A (en) 1983-01-25
PH15877A (en) 1983-04-13
PL214648A1 (ja) 1980-03-24
NO154090B (no) 1986-04-07
EP0005318B1 (en) 1982-01-06
YU50283A (en) 1983-12-31
DE2961740D1 (en) 1982-02-25
EP0005318A1 (en) 1979-11-14
JPS54151982A (en) 1979-11-29
MY8500046A (en) 1985-12-31
IL56992A (en) 1983-03-31
FI64801B (fi) 1983-09-30
RO79320A (ro) 1982-08-17
AU4529679A (en) 1979-10-18
JPS641477B2 (ja) 1989-01-11
FI64801C (fi) 1984-01-10
HU182965B (en) 1984-03-28

Similar Documents

Publication Publication Date Title
YU78479A (en) Process for obtaining new n-heterocyclyl-4-piperidine amines
YU42297B (en) Process for preparing new acylanilines
YU93179A (en) Process for obtaining 4-deacetyl-vinca-leublastin c-3-carboxhydrazide
GB2018816B (en) Process for preparing hexamethyltetrahydronaphthalenes
YU271582A (en) Process for obtaining new flavanes
DE2962201D1 (en) Process for the preparation of amines
YU36779A (en) Process for preparing new substituted 2-phenylimino-imidazolidines
YU213982A (en) Process for obtaining new erythromycyl amines
YU198879A (en) New process for obtaining benzothiazyl-disulfide
YU227679A (en) Process for obtaining n-benzylhaloacetamide deriatives
YU241279A (en) Process for obtaining 2-chlorosulfinyl-azetidine-4-one
GB2019835B (en) Process for preparing n-carbamoyl-d-thienylglycines
YU112279A (en) Process for obtaining substituted dibenzylethers
YU86879A (en) Process for obtaining 17-beta-carboxy-5-androstane-3-one
DE2961058D1 (en) Process for preparing alpha-chloro-n-monoalkyl-acetoacetamides
DE2960047D1 (en) Process for preparing 2-oximinophenylacetonitrile
YU219379A (en) Process for obtaining new 1-benzoyl-3-thiosemicarbazide
YU105179A (en) Process for obtaining new deoxyanthracyclins
YU258179A (en) New process for obtaining benzothiazole-sulfenamide
YU304478A (en) Process for obtaining chloro-acetanilides
YU215279A (en) Process for preparing new alpha-alkyl-o-oxybenzylamines
YU134179A (en) Process for obtaining n-phenethylimidazole deivatives
DE2961832D1 (en) Process for the preparation of hydro-diphenyl amines
DE2964629D1 (en) Process for preparing 3-amino-5-t-butylisoxazole
YU249778A (en) Process for obtaining new thiopropione amides